Study Evaluating Gemtuzumab Ozogamicin in Acute Myeloid Leukemia
Clinical trial NCT00037596 · COMPLETED
Trial details
- NCT number
- NCT00037596
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-08-01
- Primary completion
- 2003-04-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.